JCB logo
CrossRef
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 19 November 2001. doi:10.1083/jcb.200105009
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 615K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chidgey, M.
Right arrow Articles by Garrod, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chidgey, M.
Right arrow Articles by Garrod, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0021-9525/2001/11/821 $5.00
The Journal of Cell Biology, Volume 155, Number 5, November 26, 2001 821-832


Article

Mice lacking desmocollin 1 show epidermal fragility accompanied by barrier defects and abnormal differentiation

Martyn Chidgey1,2, Cord Brakebusch3, Erika Gustafsson3, Alan Cruchley4, Chris Hail2, Sarah Kirk1, Anita Merritt1, Alison North1, Chris Tselepis2, Jane Hewitt1, Carolyn Byrne1, Reinhard Fassler5 and David Garrod1

1 School of Biological Sciences, University of Manchester, Manchester M13 9PT, UK
2 Division of Medical Sciences, University of Birmingham, Birmingham B15 2TH, UK
3 Department of Experimental Pathology, Lund University, S-221 85 Lund, Sweden
4 Clinical and Diagnostic Oral Sciences, Barts and The London, Queen Mary's School of Medicine and Dentistry, London E1 2AT, UK
5 Department of Molecular Medicine, Max Plank Institute for Biochemistry, D-82152 Martinsried, Germany

Address correspondence to David R. Garrod, School of Biological Sciences, 3.239 Stopford Bldg., University of Manchester, Oxford Rd., Manchester M13 9PT, UK. Tel.: 44-161-275-5243. Fax: 44-161-275-3915. E-mail: david.garrod{at}man.ac.uk

The desmosomal cadherin desmocollin (Dsc)1 is expressed in upper epidermis where strong adhesion is required. To investigate its role in vivo, we have genetically engineered mice with a targeted disruption in the Dsc1 gene. Soon after birth, null mice exhibit flaky skin and a striking punctate epidermal barrier defect. The epidermis is fragile, and acantholysis in the granular layer generates localized lesions, compromising skin barrier function. Neutrophils accumulate in the lesions and further degrade the tissue, causing sloughing (flaking) of lesional epidermis, but rapid wound healing prevents the formation of overt lesions. Null epidermis is hyperproliferative and overexpresses keratins 6 and 16, indicating abnormal differentiation. From 6 wk, null mice develop ulcerating lesions resembling chronic dermatitis. We speculate that ulceration occurs after acantholysis in the fragile epidermis because environmental insults are more stringent and wound healing is less rapid than in neonatal mice. This dermatitis is accompanied by localized hair loss associated with formation of utriculi and dermal cysts, denoting hair follicle degeneration. Possible resemblance of the lesions to human blistering diseases is discussed. These results show that Dsc1 is required for strong adhesion and barrier maintenance in epidermis and contributes to epidermal differentiation.

Key Words: desmosome; desmocollin; epidermis; epidermal barrier; null mutation


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents